Working… Menu
Trial record 44 of 439 for:    colon cancer AND Capecitabine

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00126867
Recruitment Status : Terminated (Insufficient accrual and no funding)
First Posted : August 5, 2005
Last Update Posted : July 4, 2019
Information provided by (Responsible Party):
AHS Cancer Control Alberta

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 11, 2019
Actual Study Completion Date : April 11, 2019